Reassessment of c-Kit⁺ Cells for Cardiomyocyte Contribution in Adult Heart

Affiliations

• ¹ The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, China (L.H.).
• ² State Key Laboratory of Cell Biology, Chinese Academy of Sciences Center for Excellence on Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, China (L.H., M.H., Z.Z., Y.L., X.H., X.L., W.P., H.Z., B.Z.).
• ³ ShanghaiTech University, China (M.H., B.Z.).
• ⁴ Bioscience Heart Failure, Cardiovascular, Renal, and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden (Q.-D.W.).
• ⁵ State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (Y.N.).
• ⁶ Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, China (B.Z.).
• ⁷ Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China (B.Z.).
• ⁸ Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, China (B.Z.).